Dynavax Technologies | Marknadsvärde



Market Capitalization Ändra Datum
AbbVie USD 327.98B 42.66B 2025-04
Adma Biologics USD 5.13B 1.08B 2025-04
Amgen USD 155.38B 15.41B 2025-04
AstraZeneca GBP 157.7B 4.61B 2025-04
Biogen USD 17.08B 5.2B 2025-04
BioMarin Pharmaceutical USD 11.34B 1.19B 2025-04
Bristol-Myers Squibb USD 95.99B 28.11B 2025-04
Dynavax Technologies USD 1.44B 237M 2025-04
Gilead Sciences USD 128.49B 11.2B 2025-04
Glaxosmithkline USD 73.89B 4.07B 2025-04
Merck USD 200.13B 25.74B 2025-04
Neurocrine Biosciences USD 9.87B 3.95B 2025-04
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 126.33B 24.01B 2025-04
Regeneron Pharmaceuticals USD 60.81B 8.53B 2025-04
Sarepta Therapeutics USD 5.03B 6.76B 2025-04
TG Therapeutics USD 5.98B 1.29B 2025-04
Vertex Pharmaceuticals USD 127.19B 23.74B 2025-04



Dynavax Technologies Marknadsvärde - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.